UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)

Journal of hepatology, 2017, Vol.66 (1), p.S85-S85

2017

Link zum Volltext

Verfügbarkeit prüfen

P0910 : No evidence of pharmacokinetic drug–drug interaction in healthy subjects between coadministered grazoprevir (MK-5172)/elbasvir (MK-8742) and sofosbuvir

Journal of hepatology, 2015-04, Vol.62, p.S686-S686

2015

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa

Blood, 1999-07, Vol.94 (2), p.587-599

1999

Link zum Volltext

Verfügbarkeit prüfen

PS-159 - Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)

Journal of hepatology, 2017, Vol.66 (1), p.S85-S85

2017

Link zum Volltext

Verfügbarkeit prüfen

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

Clinical and translational science, 2018-11, Vol.11 (6), p.562-572

2018

Link zum Volltext

Verfügbarkeit prüfen

Fibrinogen Receptor Antagonist-Induced Thrombocytopenia in Chimpanzee and Rhesus Monkey Associated With Preexisting Drug-Dependent Antibodies to Platelet Glycoprotein IIb/IIIa

Blood, 1999-07, Vol.94 (2), p.587-599

1999

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer in Brazil: epidemiology and treatment challenges

Breast cancer targets and therapy, 2015-01, Vol.7 (default), p.43-49

2015

Link zum Volltext

Verfügbarkeit prüfen

The Adapted Resistance Training with Instability Randomized Controlled Trial for Gait Automaticity

Movement disorders, 2021-01, Vol.36 (1), p.152-163

2021

Link zum Volltext

Verfügbarkeit prüfen

Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia

Diabetes research and clinical practice, 2012-07, Vol.97 (1), p.51-56

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of the induction phase chemotherapy on cytokines and oxidative markers in peripheral and bone marrow plasma of children with acute lymphocytic leukemia

Current research in immunology, 2021, Vol.2, p.163-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry

Rapid communications in mass spectrometry, 2013-06, Vol.27 (12), p.1294-1302

2013

Link zum Volltext

Verfügbarkeit prüfen

Use of the Rorschach in forensic settings for treatment planning and monitoring

International journal of offender therapy and comparative criminology, 2002-06, Vol.46 (3), p.294-307

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)

P0910 : No evidence of pharmacokinetic drug–drug interaction in healthy subjects between coadministered grazoprevir (MK-5172)/elbasvir (MK-8742) and sofosbuvir

Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa

PS-159 - Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy

Fibrinogen Receptor Antagonist-Induced Thrombocytopenia in Chimpanzee and Rhesus Monkey Associated With Preexisting Drug-Dependent Antibodies to Platelet Glycoprotein IIb/IIIa

Breast cancer in Brazil: epidemiology and treatment challenges

The Adapted Resistance Training with Instability Randomized Controlled Trial for Gait Automaticity

Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia

Impact of the induction phase chemotherapy on cytokines and oxidative markers in peripheral and bone marrow plasma of children with acute lymphocytic leukemia

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3

Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry

Use of the Rorschach in forensic settings for treatment planning and monitoring

Suchergebnisse filtern